Drug treatment of obesity: from past failures to future successes?

No abstract is available for this paper.

• Publication year

  2001

• Venue

  British Journal of Clinical Pharmacology

• Publication date

  2001-02-13

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1046/J.1365-2125.2001.01294.XPMID 11167661PMCID PMC2014419
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Cost of Obesity

  2012cited by this paper
• Treatment of hypertension in obese patients: efficacy and feasibility of weight and salt reduction programs.

  2009cited by this paper
• Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi)

  2000cited by this paper
• Erratum to: Distribution of orexin receptor mRNA in the rat brain (FEBS 21024)

  1999cited by this paper
• Adrenoceptor genes in human obesity

  1999cited by this paper
• The effect of moxonidine on feeding and body fat in obese Zucker rats: role of hypothalamic NPY neurones

  1999cited by this paper
• Normal feeding behavior, body weight and leptin response require the neuropeptide Y Y2 receptor

  1999cited by this paper
• Effects of recombinant leptin therapy in a child with congenital leptin deficiency.

  1999cited by this paper
• Insulin-induced hypoglycemia increases preprohypocretin (orexin) mRNA in the rat lateral hypothalamic area.

  1999cited by this paper
• Long-term administration of MC4 receptor antagonist HS014 causes hyperphagia and obesity in rats.

  1999cited by this paper
• Long-term maintenance of weight loss after a very-low-calorie diet: a randomized blinded trial of the efficacy and tolerability of sibutramine.

  1999cited by this paper
• Melanin-concentrating hormone is the cognate ligand for the orphan G-protein-coupled receptor SLC-1

  1999cited by this paper
• Distribution of orexin neurons in the adult rat brain.

  1999cited by this paper
• Feeding response to central orexins.

  1999cited by this paper
• Hypothalamic orexin expression: modulation by blood glucose and feeding.

  1999cited by this paper
• Leptin: physiological actions.

  1999cited by this paper
• Hypothalamic NPY status during positive energy balance and the effects of the NPY antagonist, BW 1229U91, on the consumption of highly palatable energy-rich diet.

  1999cited by this paper
• Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation.

  1999cited by this paper
• Structure and Function of Human Prepro-orexin Gene*

  1999cited by this paper
• Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial.

  1999cited by this paper
• Thermogenic effects of sibutramine and its metabolites

  1999cited by this paper
• Sibutramine produces dose-related weight loss.

  1999cited by this paper
• The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene.

  1999cited by this paper
• The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity.

  1998cited by this paper
• A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction

  1998cited by this paper
• A frameshift mutation in MC4R associated with dominantly inherited human obesity

  1998cited by this paper
• Major biological actions of CCK – a critical evaluation of research findings

  1998cited by this paper
• Circulating leptin has saturable transport into intrathecal space in humans

  1998cited by this paper
• A selective human beta3 adrenergic receptor agonist increases metabolic rate in rhesus monkeys.

  1998cited by this paper
• Role of Orlistat in the Treatment of Obese Patients With Type 2 Diabetes: A 1-year randomized double-blind study

  1998cited by this paper
• Melanocortin mediated inhibition of feeding behavior in rats.

  1998cited by this paper
• Inhibition of the activity of dipeptidyl-peptidase IV as a treatment for type 2 diabetes.

  1998cited by this paper
• Mammalian mitochondrial uncoupling proteins.

  1998cited by this paper
• Leptin: physiology and pathophysiology.

  1998cited by this paper
• Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group.

  1998cited by this paper
• Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients

  1998cited by this paper
• Distribution of orexin receptor mRNA in the rat brain

  1998cited by this paper
• Food intake in free-feeding and energy-deprived lean rats is mediated by the neuropeptide Y5 receptor.

  1998cited by this paper
• Structural organization and mutational analysis of the human uncoupling protein-2 (hUCP2) gene.

  1998cited by this paper
• Primary and Secondary Pulmonary Hypertension

  1998cited by this paper
• Leptin and the regulation of body weight in mammals

  1998cited by this paper
• Role of β1- and β3-adrenoceptors in the regulation of lipolysis and thermogenesis in rat brown adipocytes.

  1997cited by this paper
• Sibutramine--a review of clinical efficacy.

  1997cited by this paper
• Assessing obesity: classification and epidemiology.

  1997cited by this paper
• Targeted disruption of the melanocortin-4 receptor results in obesity in mice.

  1997cited by this paper
• Mode of action of orlistat.

  1997cited by this paper
• Diet-induced obese mice develop peripheral, but not central, resistance to leptin.

  1997cited by this paper
• Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein.

  1997cited by this paper
• Congenital leptin deficiency is associated with severe early-onset obesity in humans

  1997cited by this paper
• Glucagon‐like peptide‐1 (GLP‐1): a trial of treatment in non‐insulin‐dependent diabetes mellitus

  1997cited by this paper
• The heritability of body mass index among an international sample of monozygotic twins reared apart.

  1996cited by this paper
• A role for glucagon-like peptide-1 in the central regulation of feeding

  1996cited by this paper
• Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y

  1996cited by this paper
• Leptin: The Tale of an Obesity Gene

  1996cited by this paper
• A role for melanin-concentrating hormone in the central regulation of feeding behaviour

  1996cited by this paper
• A receptor subtype involved in neuropeptide-Y-induced food intake

  1996cited by this paper
• Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group.

  1996cited by this paper
• Obesity in Britain: gluttony or sloth?

  1995cited by this paper
• Association of the Prohormone Convertase 2 Gene (PCSK2) on Chromosome 20 with NIDDM in Japanese Subjects

  1995cited by this paper
• Cholecystokinin receptors.

  1995cited by this paper
• Insulin resistance: interactions between obesity and a common variant of insulin receptor substrate-1.

  1995cited by this paper
• Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain.

  1994cited by this paper
• Chronic cerebroventricular galanin does not induce sustained hyperphagia or obesity.

  1994cited by this paper
• Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor

  1994cited by this paper
• Identification of a receptor for gamma melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system.

  1993cited by this paper
• Differential health benefits of weight loss in upper-body and lower-body obese women.

  1993cited by this paper
• Increased neuropeptide-Y messenger ribonucleic acid (mRNA) and decreased neurotensin mRNA in the hypothalamus of the obese (ob/ob) mouse.

  1993cited by this paper
• Clinical studies with the beta-adrenoceptor agonist BRL 26830A.

  1992cited by this paper
• The effect of ephedrine/caffeine mixture on energy expenditure and body composition in obese women.

  1992cited by this paper
• Altered Neuropeptide Y Concentrations in Specific Hypothalamic Regions of Obese (fa/fa) Zucker Rats: Possible Relationship to Obesity and Neuroendocrine Disturbances

  1991cited by this paper
• Neuropeptide Y suppresses sympathetic activity to interscapular brown adipose tissue in rats.

  1991cited by this paper
• The body-mass index of twins who have been reared apart.

  1990cited by this paper
• Endogenous cholecystokinin reduces feeding in young rats.

  1990cited by this paper
• Long-term effects of modest weight loss in type II diabetic patients.

  1987cited by this paper
• Primary pulmonary hypertension.

  1987cited by this paper
• High levels of energy expenditure in obese women.

  1986cited by this paper
• Neuropeptide Y chronically injected into the hypothalamus: a powerful neurochemical inducer of hyperphagia and obesity.

  1986cited by this paper
• Expression of uncoupling protein mRNA in thermogenic or weakly thermogenic brown adipose tissue. Evidence for a rapid beta-adrenoreceptor-mediated and transcriptionally regulated step during activation of thermogenesis.

  1986cited by this paper
• Neuropeptide Y distribution in the rat brain.

  1983cited by this paper
• Gastrin releasing peptide reduces meal size in rats.

  1982cited by this paper
• [Primary pulmonary hypertension].

  1964cited by this paper
• UROTHELIAL CARCINOMA ASSOCIATED WITH THE USE OF A CHINESE HERB ( ARISTOLOCHIA FANGCHI )

  year unknowncited by this paper

• Housing mice near vs. below thermoneutrality affects drug-induced weight loss but does not improve prediction of efficacy in humans

  2024cites this paper
• Efficacy and safety of tirzepatide, GLP‐1 receptor agonists, and other weight loss drugs in overweight and obesity: a network meta‐analysis

  2024cites this paper
• Quality characteristics and physiological activities of mulberry (Morus alba) vinegar

  2023cites this paper
• Basal blood concentrations of some orexigenic and anorexigenic hormones in obese and nonobese individuals according to blood groups.

  2022cites this paper
• Inhibitory Effects of Ethanol Extract of Red Sweet Pepper (Capsicum annuum L.) on Triglyceride Biosynthesis in Rhodosporidium toruloides

  2021cites this paper
• Does bariatric surgery improve adipose tissue function?

  2016cites this paper
• 카페인산의 효소적 산화반응으로부터 췌장 지방분해효소 저해 물질의 분리

  2015cites this paper
• 탱자 (Poncirus trifoliata)의 lipoprotein lipase 억제메커니즘

  2015cites this paper
• Evaluation of free radical scavenging and pancreatic lipase inhibitory effects of Aquilaria agallocha extracts

  2015cites this paper
• Secondary Metabolites from Enzymatic Oxidation of Caffeic Acid with Pancreatic Lipase Inhibitory Activity

  2015cites this paper
• Antiobesity effects of the water-soluble fraction of the ethanol extract of Smilax china L. leaf in 3T3-L1 adipocytes

  2015cites this paper
• Antioxidant and pancreatic lipase inhibitory activities of Anemarrhena asphodeloides

  2014cites this paper
• Isolation of Antioxidative Products and Evaluation of the Pancreatic Lipase Inhibitory Activity of (+)-Catechin via Thermal Treatment

  2013cites this paper
• Simultaneous Analysis and Anti-obesity Effect of Taeeumin Cheongsimyeonja-tang

  2013cites this paper
• Pancreatic Lipase Inhibitory and Antioxidant Activities of Polygonum aviculare Extract

  2011cites this paper
• Pancreatic Lipase Inhibitory and Antioxidant Activities of Zingiber officinale Extracts

  2011cites this paper
• Pancreatic Lipase Inhibitors in the Roots of Taraxacum ohwianum, a Herb Used in Korean Traditional Medicine

  2011cites this paper
• 포도씨 추출물의 항산화 효과 및 소화효소 저해 효과

  2010cites this paper
• Sibutramine & naloxone: infra-additive interaction in the regulation of appetite?

  2010cites this paper
• Sibutramine : review of its cardiovascular risk-benefit profile

  2010cites this paper
• Cardiovascular Risk-Benefit Profile of Sibutramine

  2010cites this paper
• Effects of acute low-dose combined treatment with rimonabant and sibutramine on appetite and weight gain in rats.

  2010cites this paper
• Antioxidative Effect and Digestive Enzyme Inhibition of Grape Seed Extract (GSE)

  2010cites this paper
• Pancreatic Lipase Inhibitors Isolated from the Leaves of Cultivated Mountain Ginseng (Panax ginseng)

  2010cites this paper
• Effects of acute low-dose combined treatment with naloxone and AM 251 on food intake, feeding behaviour and weight gain in rats.

  2009cites this paper
• Public awareness of the abuse of herbs and drugs to decrease body weight: a novel national survey in Jordan

  2008influential citation
• Endogenous opioids and cannabinoids: system interactions in the regulation of appetite, grooming and scratching.

  2008cites this paper
• Acute anorectic response to cannabinoid CB1 receptor antagonist/inverse agonist AM 251 in rats: indirect behavioural mediation

  2007cites this paper
• Grooming, scratching and feeding: role of response competition in acute anorectic response to rimonabant in male rats

  2007cites this paper
• Screening of medicinal plants for development of functional food ingredients with anti-obesity

  2006cites this paper
• Pharmacological and surgical treatments for obesity.

  2006cites this paper
• The prevalence of obesity and overweight in patients at a Bloemfontein private practice Scientific Letter

  2006cites this paper
• The prevalence of obesity and overweight in patients at a Bloemfontein private practice

  2006cites this paper
• Detecting adverse events in dietary supplement research: Lessons from ephedra alkaloids

  2004cites this paper
• The NMR-Derived Conformation of Orexin-A: An Orphan G-Protein Coupled Receptor Agonist Involved in Appetite Regulation and Sleep

  2003cites this paper
• Pharmacotherapy of obesity in the near term

  2003cites this paper
• Effects of systematic variation in presatiation and fasting on the behavioural satiety sequence in male rats.

  2003cites this paper
• Palatability, food intake and the behavioural satiety sequence in male rats.

  2003cites this paper
• NMR Conformational Studies of Micelle-Bound Orexin-B: A Neuropeptide Involved in the Sleep/Awake Cycle and Feeding Regulation

  2003cites this paper
• Results of obesity treatment.

  2002cites this paper
• Obesity pharmacology: past, present, and future

  2002cites this paper
• Obesity pharmacology: past, present, and future.

  2002cites this paper
• Orexins and appetite regulation.

  2002cites this paper
• Molecular pathways to obesity

  2002cites this paper